Enovis Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Enovis Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.1 times its market value (net debt). Lower than 95% of Healthcare companies in United States.
- Growth Efficiency Ratio: Sales grew 44% in 3 years, but profit fell: $171 less profit per $100 of extra sales. Lower than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
0.9×Over the last 3 years its own operating cash paid for 93% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Higher than 68% of Healthcare companies in United States.
Cash Locked Ratio
$36For every $100 of sales, $36 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $35 tied up three years earlier.
More money tied up than 76% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$171Sales grew 44% in 3 years, but profit fell: $171 less profit per $100 of extra sales.
Lower than 89% of Healthcare companies in United States.
Asset Productivity Ratio
+44% / -10%In 3 years sales changed by +44% while total assets changed by -10%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
6.2×Debt due within a year is covered 6.2 times by its yearly operating cash.
Higher than 81% of Healthcare companies in United States.
Cash Cushion Ratio
1.1× debtDebt, after subtracting cash, is 1.1 times its market value (net debt).
Lower than 95% of Healthcare companies in United States.
Tangible Assets Ratio
49%Of every $100 the company owns, $49 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 81% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 82% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Enovis Corporation made a loss over the last year. Enovis Corporation owes $0.61 for every $1 it owns. Enovis Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEnovis Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.84The share price is 0.84 times Enovis Corporation's book value per share, lower than 82% of Healthcare companies in United States.
Market cap
$1.2 BThe total market value of all of Enovis Corporation's shares at today's price (share price × number of shares), larger than 67% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.5 BWhat Enovis Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$25.61Net worth divided by the number of shares. The share price of $21.59 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
-54.1%Enovis Corporation lost 54.1% of its shareholders' money over the last year, lower than 53% of Healthcare companies in United States.
Owes vs Owns
0.61×Enovis Corporation owes $0.61 for every $1 it owns (moderate), higher than 65% of Healthcare companies in United States.
Dividend yield
NoneEnovis Corporation does not currently pay a dividend.
Revenue growth
+7%Revenue rose 7% in the year to Dec 2025, and grew 13% a year on average over 3 years.
Profit growth
LossEnovis Corporation made a loss in each of the last two years.
Profit margin
-52.7%Enovis Corporation lost $53 for every $100 of revenue.
Interest cover
Not coveredEnovis Corporation's operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtEnovis Corporation had $1.3 B more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Enovis Corporation: $1.2 B ÷ $1.5 B (30 Jun 2026) = 0.8.
What is Enovis Corporation's return on equity?
Enovis Corporation lost 54.1% of its shareholders' money over the last year, lower than 53% of Healthcare companies in United States.
How much does Enovis Corporation owe compared with what it owns?
Enovis Corporation owes $0.61 for every $1 it owns (moderate), higher than 65% of Healthcare companies in United States.
Does Enovis Corporation pay a dividend?
No. Enovis Corporation does not currently pay a dividend.
Is Enovis Corporation's revenue growing?
Revenue rose 7% in the year to Dec 2025, and grew 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.